Senores Pharmaceuticals Ltd

Intimation For Giving Corporate Guarantee For Credit Facilities Availed By Apnar Pharma Private Limited, Subsidiary Of The Company From ICICI Bank Limited

Senores Pharmaceuticals Limited has informed the Exchange regarding giving corporate guarantee for credit facilities availed by Apnar Pharma Private Limited, Subsidiary of the Company from ....

Company Update / General View filing →

Analyst / Investor Meet - Intimation

Senores Pharmaceuticals Limited has informed the Exchange regarding Analyst/ Institutional Investor Meet scheduled to be held on August 25, 2026

Company Update / Analyst / Investor Meet View filing →

Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011

The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Ashokkumar Vijaysinh Barot

Insider Trading / SAST / Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011 View filing →

Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011

The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Dhananjay Barot

Insider Trading / SAST / Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011 View filing →

Shareholder Meeting / Postal Ballot-Outcome of Postal_Ballot

Senores Pharmaceuticals Limited has informed the Exchange regarding Outcome of Postal Ballot

AGM/EGM / Postal Ballot View filing →

Shareholder Meeting / Postal Ballot-Scrutinizer"s Report

Senores Pharmaceuticals Limited has informed the Exchange regarding the Scrutinzer Report dated August 04, 2026

AGM/EGM / Postal Ballot View filing →

Newspaper Publication

Senores Pharmaceuticals Limited has informed the Exchange regarding Newspaper Publication Extracts of Unaudited Financial Results of the Company for quarter ended June 30, 2026

Company Update / Newspaper Publication View filing →

Monitoring Agency Report

Senores Pharmaceuticals Limited has informed the Exchange regarding Monitoring Agency Report for quarter ended June 30, 2026

Company Update / Monitoring Agency Report View filing →

Submission Of Statement Of Deviation Or Variation In Utilisation Of Funds Of Public Issue For Quarter Ended On June 30, 2026

Senores Pharmaceuticals Limited has informed the Exchange regarding submission of statement of deviation or variation in utilisation of funds of public issue for quarter ended June 30, 2026

Company Update / Reg. 32 (1), (3) - Statement of Deviation & Variation View filing →

Submission Of Statement Of Deviation Or Variation In Utilisation Of Funds Raised Through Preferential Issue Of Convertible Equity Warrants, For The Quarter Ended On June 30, 2026

Senores Pharmaceuticals Limited has informed the Exchange regarding submission of statement of deviation or variation in utilisation of funds raised through preferential issue of convertible ....

Company Update / Reg. 32 (1), (3) - Statement of Deviation & Variation View filing →

Analyst / Investor Meet - Outcome

Senores Pharmaceuticals Limited has informed the Exchange regarding Audio recording of Earnings Conference Call for the quarter ended June 30, 2026

Company Update / Analyst / Investor Meet View filing →

Board Meeting Intimation for Considering And Approving The Unaudited Consolidated And Standalone Financial Results Of The Company For The Quarter Ended June 30, 2026 And To Transact Other Business Matters

Senores Pharmaceuticals Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/07/2026 ,inter alia, to consider and approve to consider and approve ....

Board Meeting / Board Meeting View filing →

Analyst / Investor Meet - Intimation

Senores Pharmaceuticals Limited has informed the Exchange regarding Earnings Conference Call for Q1FY27 scheduled to be held on July 27, 2026 at 05:15 P.M. (IST)

Company Update / Analyst / Investor Meet View filing →